跳轉至內容
Merck

Management of chronic Achilles tendinopathy.

Drug and therapeutics bulletin (2012-08-10)
摘要

Tendons transmit force between muscles and bones and, when stretched, store elastic energy that contributes to movement.(1) The tendinous portion of the gastrocnemius and soleus muscles merge to form the Achilles tendon, which is the largest and strongest in the body, but one of the most frequently injured.(2,3) Conservative management options for chronic Achilles tendinopathy include eccentric (lengthening) exercises, extracorporeal shockwave therapy (ESWT), topical nitroglycerin, low level laser therapy, orthoses, splints or injections (e.g. corticosteroids, hyperosmolar dextrose, polidocanol, platelet-rich plasma), while a minority of patients require surgery (using open, percutaneous or endoscopic methods).(4-8) Here we assess the management options for patients with chronic Achilles tendinopathy (lasting over 6 weeks).

材料
產品編號
品牌
產品描述

Sigma-Aldrich
十乙二醇单十二烷基醚, nonionic surfactant
Sigma-Aldrich
Thesit®, for membrane research
Sigma-Aldrich
Brij® L23 溶液, 30 % (w/v) in H2O
Sigma-Aldrich
Brij® L23, main component: tricosaethylene glycol dodecyl ether
Sigma-Aldrich
Brij® L4聚氧乙烯月桂醚, average Mn ~362
Sigma-Aldrich
Brij® L23, suitable for Stein-Moore chromatography